Curis
CRIS
#10233
Rank
โ‚น1.35 B
Marketcap
โ‚น105.03
Share price
-10.08%
Change (1 day)
-65.31%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น332.30. In 2024 the company made an earnings per share (EPS) of -โ‚น636.52 an increase over its 2023 EPS that were of -โ‚น816.71.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.37%
2024-โ‚น636.52-22.06%
2023-โ‚น816.71-26.25%
2022-โ‚น1,10722.3%
2021-โ‚น905.44-25.37%
2020-โ‚น1,213-30.93%
2019-โ‚น1,757-2.02%
2018-โ‚น1,793
2016-โ‚น4,074-10%
2015-โ‚น4,527138.1%
2014-โ‚น1,90140%
2013-โ‚น1,358-25%
2012-โ‚น1,81166.67%
2011-โ‚น1,087

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น215.49-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น127.67-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.60-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น306.04-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.74-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น268.92-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,018 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA